CollPlant Biotechnologies (CLGN) Gains from Investment Securities (2019 - 2025)
CollPlant Biotechnologies (CLGN) reported Gains from Investment Securities of $210600.0 for Q4 2025, up 317.03% on a YoY basis from $50500.0 in Q4 2024, and up 317.03% quarter-over-quarter from $50500.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Gains from Investment Securities (2019 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Gains from Investment Securities for 6 years, with the latest figure at $210600.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 317.03% year-over-year to $210600.0; the trailing twelve-month figure through Dec 2025 stood at $210600.0 (up 317.03% YoY), and the FY2025 full-year result was $210600.0, up 317.03% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $210600.0, up from $50500.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $258000.0 in Q4 2021, with the low at $50500.0 in Q4 2024.
- Historically, Gains from Investment Securities has averaged $149137.5 across 5 years, with a median of $136500.0 in 2021.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities tumbled 68.04% — and 2025, when it soared 317.03%.
- CollPlant Biotechnologies' Gains from Investment Securities stood at $258000.0 in 2021, then retreated by 15.89% to $217000.0 in 2022, then decreased by 27.19% to $158000.0 in 2023, then plunged by 68.04% to $50500.0 in 2024, then soared by 317.03% to $210600.0 in 2025.
- The last three Gains from Investment Securities figures came in at $210600.0 (Q4 2025), $50500.0 (Q4 2024), and $158000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 210,600.00 |
| Dec 31, 2025 | 210,600.00 |
| Dec 31, 2024 | 50,500.00 |
| Dec 31, 2024 | 50,500.00 |
| Dec 31, 2023 | 158,000.00 |
| Dec 31, 2023 | 158,000.00 |
| Dec 31, 2022 | 217,000.00 |
| Dec 31, 2022 | 217,000.00 |
| Dec 31, 2021 | 258,000.00 |
| Dec 31, 2021 | 258,000.00 |
| Sep 30, 2021 | 115,000.00 |
| Sep 30, 2021 | 115,000.00 |
| Jun 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 79,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Dec 31, 2019 | 63,000.00 |
| Dec 31, 2019 | 63,000.00 |
| Mar 31, 2019 | 3.46 Mn |
| Mar 31, 2019 | 3.46 Mn |